Search
Close this search box.
Search

Eugene Borukhovich: Pharmaceutical industry has been slowly but surely moving towards the ability to bring the drugs to market quicker and much more personalized.

Digital Challenges For Pharma. Interview With Eugene Borukhovich

Eugene Borukhovich – Global Head of Digital Health & Innovation at Bayer, a founder of Health 2.0 NYC, Amsterdam & Dusseldorf local chapters – shares his thoughts with ICT&health.

How digital transformation in healthcare will influence pharmaceutical market in the next years?

First of all, digital impacts are already here and will continue challenging existing business models for years to come. If I look at the health & care ecosystem as a whole, we have health & wellness companies with direct access to the consumers and their preferences and behaviors, we have hospital systems and ACOs with direct touch to patients and healthcare consumers and health insurers, while financially focused have end customers as clients managing risk.

Patients and healthcare consumers are equipped with information. But what is missing is knowledge.

Some hospitals are launching their own generic version of drugs, insurance companies moving towards digital interactions and telemedicine and health & wellness companies are able to analyze de-identified consumer data for better prevention and help with behavior modification. Pharmaceutical industry has been slowly but surely moving towards the ability to bring the drugs to market quicker and much more personalized but also exploring other models with patient engagement in Pill+ approach. In summary, that is my concern – can we move quick enough towards personalized health & care as an industry?

The digitalization is influencing patient experience and the interactions between pharmaceutical companies, doctors and patients. How today’s healthcare models and solutions will have to be redesigned to meet unmet patients’ expectations?

Human-centric design has become a bit of a buzzword by itself, however I truly believe that any large health care company has to take this approach: understanding unmet needs of healthcare consumers. The other aspect of the changes that are already taking place is the notion of “cooperation is the new competition” – no large or small company can do things on their own and that is our hypothesis at G4A.

Usually patients – if not hospitalized – buy medicines in a pharmacy after asking friends for recommendations, googling symptoms in internet or visiting a doctor. How this “patient’s journey” will change in the future?

I will not be the first one to say that “googling” has been going on for many years and patients and healthcare consumers have been and will continue being more equipped with information. But what is missing is knowledge. There is also tremendous institutional knowledge with our key opinion leaders and practitioners but given the amount of information coming on daily basis, turning this information into knowledge will require the use of latest technologies (will skip all the buzz words) to arm and augment the physicians but also direct to consumer platforms. Unless, one gets diagnosed with a disease, the knowledge level of healthcare consumers and the multitude of potentially “untrusted” sources is still there.

Could you name three startups solutions that fascinate you most recently?

Too many to pick three from but to give a hint, I am excited about what digital therapeutics and Neuro Tech startups are doing in the space. From Virtual Reality to music-as-medicine, the brain holds some key answers to our current challenges in the quest for personalization.

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Doximity_edited
Innovation Adoption: How to Traverse The Valleys of Death
Data protection-critical incidents resulting from human error are often rooted in stress, routine, negative attitudes toward IT, and deficits in employees' identification with the healthcare facility.
How cyberpsychology helps prevent human errors leading to data leaks
Follow us